About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 492 record(s)
Req # A-2023-000063
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-101700-489.Organization: Public Health Agency of Canada
December 2023
Req # A-2023-000099
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-103489-421.Organization: Public Health Agency of Canada
December 2023
Req # A-2023-000129
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 23-108088-65, National Quarterly Updates on Opioid- and Stimulant-related Harms in Canada.Organization: Public Health Agency of Canada
December 2023
Nothing to report this month
Organization: Canada Lands Company CLC Limited
Req # A-2018-001621
Adverse Drug Reactions (ADRs). Report numbers: E2B_01876090, E2B_01338065, E2B_02190267, E2B_01942726, E2B_01475225, E2B_01776362, E2B_01955738, E2B_01940173Organization: Health Canada
December 2022
Req # A-2019-001654
Adverse Drug Reactions (ADRs) for PREDNISOLONE. Report numbers: 000719680, E2B_02529865, E2B_02030519, E2B_02515291, E2B_02050563, E2B_02484589, E2B_02564514, E2B_02644290, E2B_02409379, E2B_02405284, E2B_02564514, E2B_02283612, E2B_02288634, E2B_02340759, E2B_02343409, E2B_02110537, E2B_02197044, E2B_02231445, E2B_02094176, E2B_02251355.Organization: Health Canada
December 2022
Req # A-2020-000123
Adverse Drug Reaction (ADR). Report number: 000731022.Organization: Health Canada
December 2022
Req # A-2020-001368
Adverse Drug Reactions (ADRs) for ENOXAPARIN SODIUM. Report numbers: 000908390, 000912874.Organization: Health Canada
December 2022
Req # A-2020-001861
Adverse Drug Reactions (ADRs) for Janumet. Report numbers: E2B_01294965, E2B_01319676, E2B_01387851, E2B_01648958, E2B_00412992, E2B_01322417, E2B_01653190, E2B_00280827.Organization: Health Canada
December 2022
Req # A-2021-001526
Adverse Drug Reactions (ADRs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03523213, 953443, E2B_03577001, E2B_03733340, E2B_03526016, E2B_03525423, E2B_03693115, E2B_03698695, E2B_03753478, E2B_03726769, E2B_03578415, E2B_03753511, E2B_03767290, E2B_03736254, E2B_02529659, E2B_03705225, E2B_03791084, E2B_03774153, E2B_03753476.Organization: Health Canada
December 2022